380 related articles for article (PubMed ID: 33187478)
21. Oral ganciclovir for cytomegalovirus retinitis in patients with AIDS: results of two randomized studies.
Squires KE
AIDS; 1996 Dec; 10 Suppl 4():S13-8. PubMed ID: 9110065
[TBL] [Abstract][Full Text] [Related]
22. High-dose (2000-microgram) intravitreous ganciclovir in the treatment of cytomegalovirus retinitis.
Young S; Morlet N; Besen G; Wiley CA; Jones P; Gold J; Li Y; Freeman WR; Coroneo MT
Ophthalmology; 1998 Aug; 105(8):1404-10. PubMed ID: 9709750
[TBL] [Abstract][Full Text] [Related]
23. Treatment of cytomegalovirus retinitis in AIDS patients using intravitreal injections of highly concentrated ganciclovir.
Baudouin C; Chassain C; Caujolle C; Gastaud P
Ophthalmologica; 1996; 210(6):329-35. PubMed ID: 8887389
[TBL] [Abstract][Full Text] [Related]
24. The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial.
Studies of Ocular Complications of AIDS Research Group. The AIDS Clinical Trials Group.
Am J Ophthalmol; 2001 Apr; 131(4):457-67. PubMed ID: 11292409
[TBL] [Abstract][Full Text] [Related]
25. Rate of emergence of cytomegalovirus (CMV) mutations in leukocytes of patients with acquired immunodeficiency syndrome who are receiving valganciclovir as induction and maintenance therapy for CMV retinitis.
Boivin G; Gilbert C; Gaudreau A; Greenfield I; Sudlow R; Roberts NA
J Infect Dis; 2001 Dec; 184(12):1598-602. PubMed ID: 11740736
[TBL] [Abstract][Full Text] [Related]
26. Treatment of cytomegalovirus retinitis with oral valganciclovir in an acquired immunodeficiency syndrome patient unresponsive to combination antiretroviral therapy.
Lee CH; Bright DC; Ferrucci S
Optometry; 2006 Apr; 77(4):167-76. PubMed ID: 16567278
[TBL] [Abstract][Full Text] [Related]
27. Valganciclovir: a new treatment for cytomegalovirus retinitis.
Marco M
BETA; 2002; 15(1):19-21. PubMed ID: 12141246
[No Abstract] [Full Text] [Related]
28. Therapeutic developments in cytomegalovirus retinitis.
Hoffman VF; Skiest DJ
Expert Opin Investig Drugs; 2000 Feb; 9(2):207-20. PubMed ID: 11060672
[TBL] [Abstract][Full Text] [Related]
29. Outcome of cytomegalovirus retinitis in immunocompromised patients without Human Immunodeficiency Virus treated with intravitreal ganciclovir injection.
Agarwal A; Kumari N; Trehan A; Khadwal A; Dogra MR; Gupta V; Sharma A; Gupta A; Singh R
Graefes Arch Clin Exp Ophthalmol; 2014 Sep; 252(9):1393-401. PubMed ID: 24557658
[TBL] [Abstract][Full Text] [Related]
30. Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant.
Muccioli C; Belfort R
Braz J Med Biol Res; 2000 Jul; 33(7):779-89. PubMed ID: 10881053
[TBL] [Abstract][Full Text] [Related]
31. Cytomegalovirus retinitis successfully treated with ganciclovir implant in a patient with blood ganciclovir resistance and ocular ganciclovir sensitivity.
Bakshi NK; Fahle GA; Sereti I; Wiley H; Nussenblatt RB; Sen HN
Eye (Lond); 2012 May; 26(5):759-60. PubMed ID: 22322999
[No Abstract] [Full Text] [Related]
32. Visual prognosis of AIDS patients with cytomegalovirus retinitis.
Bloom PA; Sandy CJ; Migdal CS; Stanbury R; Graham EM
Eye (Lond); 1995; 9 ( Pt 6)():697-702. PubMed ID: 8849536
[TBL] [Abstract][Full Text] [Related]
33. Cytomegalovirus retinitis: the neglected disease of the AIDS pandemic.
Heiden D; Ford N; Wilson D; Rodriguez WR; Margolis T; Janssens B; Bedelu M; Tun N; Goemaere E; Saranchuk P; Sabapathy K; Smithuis F; Luyirika E; Drew WL
PLoS Med; 2007 Dec; 4(12):e334. PubMed ID: 18052600
[TBL] [Abstract][Full Text] [Related]
34. Comparison of two different intravitreal treatment regimens combined with systemic antiviral therapy for cytomegalovirus retinitis in patients with AIDS.
Liang X; An H; He H; Shen B; Ou Z; Li L
AIDS Res Ther; 2023 Jul; 20(1):46. PubMed ID: 37452370
[TBL] [Abstract][Full Text] [Related]
35. Cytomegalovirus retinitis in AIDS patients: a comparative study of intravenous and oral ganciclovir as maintenance therapy.
Danner SA; Matheron S
AIDS; 1996 Dec; 10 Suppl 4():S7-11. PubMed ID: 9110064
[TBL] [Abstract][Full Text] [Related]
36. Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir.
Jabs DA
Infect Agents Dis; 1995 Sep; 4(3):131-42. PubMed ID: 8548191
[TBL] [Abstract][Full Text] [Related]
37. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
Arch Ophthalmol; 1996 Jan; 114(1):23-33. PubMed ID: 8540847
[TBL] [Abstract][Full Text] [Related]
38. Cytomegalovirus resistance to ganciclovir and clinical outcomes of patients with cytomegalovirus retinitis.
Jabs DA; Martin BK; Forman MS; Hubbard L; Dunn JP; Kempen JH; Davis JL; Weinberg DV;
Am J Ophthalmol; 2003 Jan; 135(1):26-34. PubMed ID: 12504693
[TBL] [Abstract][Full Text] [Related]
39. High dose oral ganciclovir treatment for cytomegalovirus retinitis.
Lalezari JP; Friedberg DN; Bissett J; Giordano MF; Hardy WD; Drew WL; Hubbard LD; Buhles WC; Stempien MJ; Georgiou P; Jung DT; Robinson CA;
J Clin Virol; 2002 Feb; 24(1-2):67-77. PubMed ID: 11744430
[TBL] [Abstract][Full Text] [Related]
40. EFFICACY OF MARIBAVIR IN VALGANCICLOVIR-RESISTANT CYTOMEGALOVIRUS RETINITIS.
Tsui JC; Huang V; Kolomeyer AM; Miller CG; Mishkin A; Maguire AM
Retin Cases Brief Rep; 2024 Mar; 18(2):164-167. PubMed ID: 36730596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
